{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:16:41Z","timestamp":1791407801998,"version":"4.3.3"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009337","name":"Saitama Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24K11435"],"award-info":[{"award-number":["24K11435"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jbc.2025.111029","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:09:48Z","timestamp":1765296588000},"page":"111029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["PKM2 inhibitor suppresses kidney fibrogenesis by disrupting YAP-TEAD-CCN2 transcriptional signaling following ischemia\u2013reperfusion injury"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8386-441X","authenticated-orcid":false,"given":"Wakako","family":"Kosakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.111029_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.111029_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/j.ajkd.2021.11.010","article-title":"Antifibrotic agents for the management of CKD: a review","volume":"80","author":"Ruiz-Ortega","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jbc.2025.111029_bib3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","article-title":"Acute kidney injury","volume":"7","author":"Kellum","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jbc.2025.111029_bib4","first-page":"151","article-title":"High burden and unmet patient needs in chronic kidney disease","volume":"5","author":"Braun","year":"2012","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"10.1016\/j.jbc.2025.111029_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/10985549.2023.2253130","article-title":"Module 4-deficient CCN2\/connective tissue growth factor attenuates the progression of renal fibrosis via suppression of focal adhesion kinase phosphorylation in tubular epithelial cells","volume":"43","author":"Amano","year":"2023","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2025.111029_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbrc.2019.07.024","article-title":"Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease","volume":"517","author":"Inoue","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2025.111029_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1681\/ASN.2004040339","article-title":"Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis","volume":"16","author":"Okada","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jbc.2025.111029_bib8","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1681\/ASN.2020081143","article-title":"Single-nucleus RNA sequencing identifies new classes of proximal tubular epithelial cells in kidney fibrosis","volume":"32","author":"Lu","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jbc.2025.111029_bib9","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.3390\/molecules27217318","article-title":"The role of hypoxia-inducible factor-1 alpha in renal disease","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jbc.2025.111029_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcdb.2015.08.004","article-title":"Pyruvate kinase: function, regulation and role in cancer","volume":"43","author":"Israelsen","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2025.111029_bib11","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.15252\/embr.201643300","article-title":"PKM2, cancer metabolism, and the road ahead","volume":"17","author":"Dayton","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jbc.2025.111029_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2025.111029_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature08697","article-title":"HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer","volume":"463","author":"David","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.111029_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.111029_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fonc.2020.00159","article-title":"Pyruvate kinase M2 and cancer: the role of PKM2 in promoting tumorigenesis","volume":"10","author":"Zahra","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbc.2025.111029_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2012.07.018","article-title":"PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis","volume":"150","author":"Yang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.111029_bib17","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.molcel.2012.01.001","article-title":"Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase","volume":"45","author":"Gao","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2025.111029_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","article-title":"The hippo signalling pathway and its implications in human health and diseases","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jbc.2025.111029_bib19","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","volume":"22","author":"Zhao","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2025.111029_bib20","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.15252\/embj.201490379","article-title":"Aerobic glycolysis tunes YAP\/TAZ transcriptional activity","volume":"34","author":"Enzo","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2025.111029_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature10598","article-title":"Nuclear PKM2 regulates \u03b2-catenin transactivation upon EGFR activation","volume":"480","author":"Yang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.111029_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41581-020-00343-w","article-title":"WNT-\u03b2-catenin signalling - a versatile player in kidney injury and repair","volume":"17","author":"Schunk","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jbc.2025.111029_bib23","article-title":"Inhibition of PKM2 by shikonin impedes TGF-\u03b21 expression by repressing histone lactylation to alleviate renal fibrosis","volume":"136","author":"Xiang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jbc.2025.111029_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11481-024-10138-6","article-title":"Tetramerization of PKM2 alleviates traumatic brain injury by ameliorating mitochondrial damage in microglia","volume":"19","author":"Zhu","year":"2024","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.jbc.2025.111029_bib25","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.ajpath.2020.08.002","article-title":"Pyruvate kinase M2 tetramerization protects against hepatic stellate cell activation and liver fibrosis","volume":"190","author":"Zheng","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jbc.2025.111029_bib26","article-title":"Targeting pyruvate kinase M2 for the treatment of kidney disease","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2025.111029_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1213473","article-title":"Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease","volume":"14","author":"Dai","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2025.111029_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129034","article-title":"Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules","volume":"5","author":"Li","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2025.111029_bib29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nm.4328","article-title":"Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction","volume":"23","author":"Qi","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2025.111029_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13548","article-title":"Pyruvate kinase M2 regulates kidney fibrosis through pericyte glycolysis during the progression from acute kidney injury to chronic kidney disease","volume":"57","author":"Chen","year":"2024","journal-title":"Cell Prolif"},{"key":"10.1016\/j.jbc.2025.111029_bib31","article-title":"Metabolic reprogramming and renal fibrosis","volume":"8","author":"Zhu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jbc.2025.111029_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1073\/pnas.1311249111","article-title":"JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1alpha-mediated glucose metabolism","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.111029_bib33","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.7150\/ijbs.59855","article-title":"Specific pyruvate kinase M2 inhibitor, compound 3K, induces autophagic cell death through disruption of the glycolysis pathway in ovarian cancer cells","volume":"17","author":"Park","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jbc.2025.111029_bib34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI0215518","article-title":"Evidence that fibroblasts derive from epithelium during tissue fibrosis","volume":"110","author":"Iwano","year":"2002","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.jbc.2025.111029_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nn.2467","article-title":"A robust and high-throughput Cre reporting and characterization system for the whole mouse brain","volume":"13","author":"Madisen","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jbc.2025.111029_bib36","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41419-021-04041-8","article-title":"Hippo-YAP\/MCP-1 mediated tubular maladaptive repair promote inflammation in renal failed recovery after ischemic AKI","volume":"12","author":"Zheng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2025.111029_bib37","doi-asserted-by":"crossref","first-page":"9971","DOI":"10.1074\/jbc.M508778200","article-title":"Phosphorylation of \u03b2-catenin by cyclic AMP-dependent protein kinase","volume":"281","author":"Taurin","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.111029_bib38","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.3390\/molecules30173457","article-title":"Metabolism, a blossoming target for small-molecule anticancer drugs","volume":"30","author":"Puxeddu","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.jbc.2025.111029_bib39","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1007\/s00432-022-04501-4","article-title":"Small molecule inhibitors for cancer metabolism: promising prospects to be explored","volume":"149","author":"Liu","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jbc.2025.111029_bib40","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.bcp.2009.12.003","article-title":"Identification of small molecule inhibitors of pyruvate kinase M2","volume":"79","author":"Vander Heiden","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2025.111029_bib41","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1101\/gad.274951.115","article-title":"\u03b1E-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of hippo signaling pathway","volume":"30","author":"Li","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2025.111029_bib42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fphys.2015.00082","article-title":"TGF-\u03b2\/Smad signaling in renal fibrosis","volume":"6","author":"Meng","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jbc.2025.111029_bib43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.200903-0322OC","article-title":"Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis","volume":"180","author":"Tanjore","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jbc.2025.111029_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021911","article-title":"CCN2 is required for the TGF-\u03b2 induced activation of Smad1-Erk1\/2 signaling network","volume":"6","author":"Nakerakanti","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.111029_bib45","article-title":"Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jbc.2025.111029_bib46","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.7150\/thno.32915","article-title":"Metastatic colorectal cancer rewrites metabolic program through a Glut3\u2013YAP-dependent signaling circuit","volume":"9","author":"Kuo","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jbc.2025.111029_bib47","doi-asserted-by":"crossref","first-page":"8184","DOI":"10.3390\/ijms21218184","article-title":"Inhibition of yes-associated protein by verteporfin ameliorates unilateral ureteral obstruction-induced renal tubulointerstitial inflammation and fibrosis","volume":"21","author":"Jin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2025.111029_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1171637","article-title":"Generation and characterization of an inducible renal proximal tubule-specific CreERT2 mouse","volume":"11","author":"Liang","year":"2023","journal-title":"Front. Cell Dev. Biol"},{"key":"10.1016\/j.jbc.2025.111029_bib49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ki.2013.368","article-title":"Lineage-tracing methods and the kidney","volume":"86","author":"Humphreys","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.jbc.2025.111029_bib50","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/s42255-022-00615-8","article-title":"Analyzing cell-type-specific dynamics of metabolism in kidney repair","volume":"4","author":"Wang","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jbc.2025.111029_bib51","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1038\/s41467-022-33623-z","article-title":"Enhanced metanephric specification to functional proximal tubule enables toxicity screening and infectious disease modelling in kidney organoids","volume":"13","author":"Vanslambrouck","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.111029_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51343-1","article-title":"Hypoxia-inducible factor-1alpha is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy","volume":"9","author":"Bessho","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.111029_bib53","first-page":"4101","article-title":"YAP-mediated crosstalk between the Wnt and hippo signaling pathways","volume":"22","author":"Jiang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jbc.2025.111029_bib54","first-page":"59","article-title":"Signaling in fibrosis: Tgf-\u03b2, WNT, and YAP\/TAZ converge","volume":"2","author":"Piersma","year":"2015","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jbc.2025.111029_bib55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13578-019-0317-8","article-title":"PKM2, function and expression and regulation","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.jbc.2025.111029_bib56","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/s12935-020-01612-1","article-title":"Protein kinase function of pyruvate kinase M2 and cancer","volume":"20","author":"Chen","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jbc.2025.111029_bib57","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/CS20150385","article-title":"Involvement of the hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector","volume":"130","author":"Xu","year":"2016","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.jbc.2025.111029_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo0987","article-title":"PKM2 promotes pulmonary fibrosis by stabilizing TGF-\u03b21 receptor I and enhancing TGF-\u03b21 signaling","volume":"8","author":"Gao","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2025.111029_bib59","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nchembio.1060","article-title":"Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis","volume":"8","author":"Anastasiou","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2025.111029_bib60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2017.06.064","article-title":"Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase","volume":"138","author":"Ning","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2025.111029_bib61","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/jdi.13478","article-title":"The PKM2 activator TEPP-46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF-1\u03b1 accumulation","volume":"12","author":"Liu","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.jbc.2025.111029_bib62","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/ijms26031358","article-title":"Gender differences in adenine diet-induced kidney toxicity: the impact of 17\u03b2-estradiol on renal inflammation and fibrosis","volume":"26","author":"Ha","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2025.111029_bib63","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/ndt\/14.9.2130","article-title":"Regulation of hyaluronan-stimulated VCAM-1 expression in murine renal tubular epithelial cells","volume":"14","author":"Schawalder","year":"1999","journal-title":"Nephrol. Dial. Transpl."}],"updated-by":[{"DOI":"10.1016\/j.jbc.2026.111452","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825028819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825028819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:57:46Z","timestamp":1773939466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825028819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0021925825028819"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.111029","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PKM2 inhibitor suppresses kidney fibrogenesis by disrupting YAP-TEAD-CCN2 transcriptional signaling following ischemia\u2013reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.111029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111029"}}